Literature DB >> 6245672

Selective macrophage inhibition abolishes warfarin-induced reduction of metastasis.

B Maat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6245672      PMCID： PMC2010214          DOI： 10.1038/bjc.1980.46

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  24 in total

1.  Demonstration of fibrin in early stages of experimental metastases.

Authors:  E C Chew; A C Wallace
Journal:  Cancer Res       Date:  1976-06       Impact factor: 12.701

2.  Activated macrophages and the antitumor action of BCG.

Authors:  P Alexander
Journal:  Natl Cancer Inst Monogr       Date:  1973-12

3.  The anticoagulant activity of carrageenan.

Authors:  W Anderson; J G Duncan
Journal:  J Pharm Pharmacol       Date:  1965-10       Impact factor: 3.765

4.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

5.  Suppression of in vitro antigen-induced lymphocyte transformation by carrageenan, a macrophage-toxic agent.

Authors:  W W Lake; D Bice; H J Schwartz; J Salvaggio
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

6.  The ineffectiveness of coumarin treatment on thermal oedema of macrophage-free rats.

Authors:  N B Piller
Journal:  Br J Exp Pathol       Date:  1976-04

7.  [Effect of a Melilotus preparation on the activity of the reticuloendothelial system].

Authors:  A G Kovách; M Földi; I Szlamka; A Ecker; M Hámori
Journal:  Arztl Forsch       Date:  1965-11-10

8.  Evaluation of carrageenan as an immunosuppressive agent and mediator of intravascular coagulation.

Authors:  A W Thomson; A R Wilson; W J Cruickshank; C H Horne
Journal:  Biomedicine       Date:  1976-05

9.  Spectrum and possible mechanism of carrageenan cytotoxicity.

Authors:  P J Catanzaro; H J Schwartz; R C Graham
Journal:  Am J Pathol       Date:  1971-08       Impact factor: 4.307

10.  An examination of the cytotoxic effects of silica on macrophages.

Authors:  A C Allison; J S Harington; M Birbeck
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307
View more
  9 in total

Review 1.  [Hematologic or hemostaseologic "paraneoplastic syndromes" as prognostic factors?].

Authors:  W Schneider
Journal:  Klin Wochenschr       Date:  1988-02-01

2.  Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer.

Authors:  P T T Kinnunen; T J Murtola; K Talala; K Taari; T L J Tammela; A Auvinen
Journal:  Cancer Causes Control       Date:  2019-06-17       Impact factor: 2.506

3.  The first international urokinase/warfarin trial in colorectal cancer.

Authors:  L Daly
Journal:  Clin Exp Metastasis       Date:  1991 Jan-Feb       Impact factor: 5.150

4.  Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy.

Authors:  Garth W Tormoen; Tiffany C Blair; Shelly Bambina; Gwen Kramer; Jason Baird; Ramtin Rahmani; John M Holland; Owen J T McCarty; Michael J Baine; Vivek Verma; Nima Nabavizadeh; Michael J Gough; Marka Crittenden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-18       Impact factor: 7.038

Review 5.  Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

Authors:  Nicole M Kuderer; Thomas L Ortel; Charles W Francis
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 6.  Role of plasma, platelets, and endothelial cells in tumor metastasis.

Authors:  G J Gasic
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  The effect of therapeutic anticoagulation on overall survival in men receiving first-line docetaxel chemotherapy for metastatic castration-resistant prostate cancer.

Authors:  Jong Chul Park; Caroline F Pratz; Anteneh Tesfaye; Robert A Brodsky; Emmanuel S Antonarakis
Journal:  Clin Genitourin Cancer       Date:  2014-06-11       Impact factor: 2.872

8.  Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems.

Authors:  B Maat; P Hilgard
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

9.  Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer.

Authors:  Pete T T Kinnunen; Teemu J Murtola; Kirsi Talala; Kimmo Taari; Teuvo L J Tammela; Anssi Auvinen
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.